Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1992 | 09-1992 | 06-1992 | 03-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,463 | N/A | N/A | N/A | 4,173 |
| Depreciation Amortization | 10,875 | N/A | N/A | N/A | 9,792 |
| Other Working Capital | -12,419 | N/A | N/A | N/A | 10,043 |
| Other Operating Activity | 4,409 | 0 | 0 | 0 | -987 |
| Operating Cash Flow | $9,328 | $N/A | $N/A | $N/A | $23,021 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58,324 | N/A | N/A | N/A | -28,683 |
| Other Investing Activity | 2,030 | 0 | 0 | 0 | 1,574 |
| Investing Cash Flow | $-56,294 | $N/A | $N/A | $N/A | $-27,109 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -9,063 | N/A | N/A | N/A | -6,013 |
| Other Financing Activity | 56,365 | 0 | 0 | 0 | 8,626 |
| Financing Cash Flow | $47,302 | $N/A | $N/A | $N/A | $2,613 |
| Beginning Cash Position | 727 | N/A | N/A | N/A | 2,202 |
| End Cash Position | 1,063 | N/A | N/A | N/A | 727 |
| Net Cash Flow | $336 | $N/A | $N/A | $N/A | $-1,475 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,328 | N/A | N/A | N/A | 23,021 |
| Free Cash Flow | 9,328 | 0 | 0 | 0 | 23,021 |